Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Nutex Health (NUTX) Cash from Operations (2016 - 2026)

Nutex Health (NUTX) has disclosed Cash from Operations for 17 consecutive years, with 75518000.0 as the latest value for Q1 2026.

For Q1 2026, Cash from Operations rose 48.18% year-over-year to 75518000.0; the TTM value through Mar 2026 reached 272678000.0, up 283.69%, while the annual FY2025 figure was 248125000.0, 971.68% up from the prior year.
Cash from Operations hit 75518000.0 in Q1 2026 for Nutex Health, up from 70389000.0 in the prior quarter.
Across five years, Cash from Operations topped out at 99514000.0 in Q3 2025 and bottomed at 7301945.0 in Q3 2022.
Average Cash from Operations over 5 years is 23450594.59, with a median of 6788000.0 recorded in 2024.
Year-over-year, Cash from Operations crashed 139.41% in 2023 and then surged 130250.0% in 2025.
Nutex Health's Cash from Operations stood at 4505994.0 in 2022, then plummeted by 139.41% to 1775670.0 in 2023, then surged by 103.04% to 54000.0 in 2024, then soared by 130250.0% to 70389000.0 in 2025, then grew by 7.29% to 75518000.0 in 2026.
According to Business Quant data, Cash from Operations over the past three periods came in at 75518000.0, 70389000.0, and 99514000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.